T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.99% |
| 2 | Healthcare | 16.87% |
| 3 | Consumer Discretionary | 15.81% |
| 4 | Financials | 11.47% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
First Business Financial Services
FBIZ
$584M
| $420K | ﹤0.01% |
29,411
| – | – |
|
2152
Peapack-Gladstone Financial
PGC
$791M
| $420K | ﹤0.01% |
27,705
| – | – |
|
|
VSLR
2153
DELISTED
VIVINT SOLAR, INC.
VSLR
| $420K | ﹤0.01% |
+9,922
| New | +$256K |
|
2154
World Acceptance Corp
WRLD
$805M
| $418K | ﹤0.01% |
3,957
| – | – |
|
2155
LeMaitre Vascular
LMAT
$1.86B
| $417K | ﹤0.01% |
12,817
| – | – |
|
|
MDLA
2156
DELISTED
Medallia, Inc.
MDLA
| $417K | ﹤0.01% |
+15,201
| New | +$461K |
|
2157
Editas Medicine
EDIT
$375M
| $415K | ﹤0.01% |
+14,773
| New | +$481K |
|
|
ORC
2158
Orchid Island Capital
ORC
$1.12B
| $414K | ﹤0.01% |
16,530
-60
| -0.4% | -$1.5K |
|
2159
Evolent Health
EVH
$413M
| $413K | ﹤0.01% |
33,304
-19,100
| -36% | -$225K |
|
2160
Tennant Co
TNC
$1.15B
| $413K | ﹤0.01% |
6,838
-4,220
| -38% | -$279K |
|
|
VCRA
2161
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $413K | ﹤0.01% |
14,192
+3,704
| +35% | +$100K |
|
2162
Helmerich & Payne
HP
$3.86B
| $412K | ﹤0.01% |
+28,090
| New | +$489K |
|
|
MAGN
2163
Magnera Corp
MAGN
$425M
| $412K | ﹤0.01% |
2,300
-400
| -15% | -$79.9K |
|
2164
Rio Tinto
RIO
$152B
| $411K | ﹤0.01% |
6,804
| – | – |
|
2165
Anavex Life Sciences
AVXL
$218M
| $410K | ﹤0.01% |
90,092
-70
| -0.1% | -$301 |
|
|
SRDX
2166
DELISTED
Surmodics
SRDX
| $409K | ﹤0.01% |
10,503
-1,000
| -9% | -$43.9K |
|
|
HIBB
2167
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $408K | ﹤0.01% |
10,393
-42
| -0.4% | -$1.22K |
|
2168
Core Laboratories
CLB
$474M
| $407K | ﹤0.01% |
26,680
+4,000
| +18% | +$83.9K |
|
2169
Global Industrial
GIC
$1.59B
| $406K | ﹤0.01% |
16,979
-1,500
| -8% | -$32.4K |
|
2170
Universal Electronics
UEIC
$67.8M
| $406K | ﹤0.01% |
10,771
-1,997
| -16% | -$86.7K |
|
|
COOP
2171
DELISTED
Mr. Cooper
COOP
| $401K | ﹤0.01% |
17,961
-46
| -0.3% | -$793 |
|
2172
Center Bancorp
CNOB
$1.54B
| $400K | ﹤0.01% |
28,452
-3,200
| -10% | -$46.6K |
|
|
CETV
2173
DELISTED
Central European Media Enterprises Ltd
CETV
| $398K | ﹤0.01% |
95,007
-1,526,899
| -94% | -$6.22M |
|
2174
Inspire Medical Systems
INSP
$2.05B
| $396K | ﹤0.01% |
+3,066
| New | +$338K |
|
|
RDS.A
2175
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $396K | ﹤0.01% |
15,750
-1,600
| -9% | -$48.4K |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.